Dogwood Therapeutics, Inc. SEC filings DWTX
Dogwood Therapeutics, Inc. has 328 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 16, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 16, 2026 |
| DEF 14A | Proxy statement | Feb 13, 2026 | Mar 11, 2026 |
| PRE 14A | Preliminary proxy statement | Jan 23, 2026 | Mar 11, 2026 |
| DEF 14A | Proxy statement | Oct 20, 2025 | Nov 21, 2025 |
| DEFA14A | Additional proxy material | Oct 9, 2025 | — |
| PRE 14A | Preliminary proxy statement | Oct 8, 2025 | Nov 21, 2025 |
| DEFA14A | Additional proxy material | Sep 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| DEFA14A | Additional proxy material | Oct 7, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 18, 2024 |
| DEFA14A | Additional proxy material | Feb 27, 2024 | — |
| DEF 14A | Proxy statement | Feb 2, 2024 | Mar 1, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 22, 2024 | Mar 1, 2024 |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 15, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 13, 2023 | Jun 15, 2023 |
| DEFA14A | Additional proxy material | May 16, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 16, 2022 |
| DEFA14A | Additional proxy material | Jun 3, 2021 | — |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 22, 2021 |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alpharetta, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1818844
- Former names
- Virios Therapeutics, Inc. (until Oct 15, 2024); Virios Therapeutics, LLC (until Dec 16, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.